Ocugen (OCGN) Shares Outstanding (2014 - 2026)
Ocugen (OCGN) posted Shares Outstanding (Entity) of $50.2 million for Q4 2025, up 1.2% on a QoQ basis from $49.6 million in Q3 2025, and up 156.26% year-over-year from $19.6 million in Q4 2024.
Ocugen (OCGN) Shares Outstanding (2014 - 2026) Analysis & Trends
Ocugen's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $50.2 million for Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 156.26% year-over-year to $50.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.2 million (up 156.26% YoY) and the FY2025 annual result came in at $50.2 million, up 156.26% from the prior year.
- Shares Outstanding (Entity) was $50.2 million for Q4 2025 at Ocugen, up from $49.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $238.3 million in Q2 2023 and bottomed at $19.6 million in Q4 2024.
- A 5-year average of $152.6 million and a median of $199.0 million in 2021 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 256.95% — and 2023, when it gained 5.0%.
- Ocugen's Shares Outstanding (Entity) stood at $199.5 million in 2021, then increased by 11.14% to $221.7 million in 2022, then grew by 7.48% to $238.3 million in 2023, then slumped by 91.78% to $19.6 million in 2024, then surged by 156.26% to $50.2 million in 2025.
- Business Quant data shows OCGN's Shares Outstanding (Entity) at $50.2 million in Q4 2025, $49.6 million in Q3 2025, and $29.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 327.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327.54 Mn |
| Dec 31, 2025 | 50.23 Mn |
| Sep 30, 2025 | 49.63 Mn |
| Jun 30, 2025 | 28.95 Mn |
| Mar 31, 2025 | 292.00 Mn |
| Dec 31, 2024 | 19.60 Mn |
| Sep 30, 2024 | 19.64 Mn |
| Jun 30, 2024 | 257.35 Mn |
| Mar 31, 2024 | 257.23 Mn |
| Dec 31, 2023 | 244.33 Mn |
| Sep 30, 2023 | 256.49 Mn |
| Jun 30, 2023 | 238.31 Mn |
| Mar 31, 2023 | 225.52 Mn |
| Dec 31, 2022 | 214.60 Mn |
| Sep 30, 2022 | 216.59 Mn |
| Jun 30, 2022 | 215.86 Mn |
| Mar 31, 2022 | 205.69 Mn |
| Dec 31, 2021 | 195.01 Mn |
| Sep 30, 2021 | 198.79 Mn |
| Jun 30, 2021 | 195.57 Mn |